Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,308 | -5,469 | -4,534 | -3,244 | -1,423 |
| Depreciation Amortization | 30 | 592 | 559 | 521 | 120 |
| Accounts receivable | N/A | -26 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 294 | -252 | -140 | -118 | -121 |
| Other Working Capital | 305 | -72 | -12 | 50 | 67 |
| Other Operating Activity | -111 | 851 | 619 | 424 | 227 |
| Operating Cash Flow | $-791 | $-4,376 | $-3,508 | $-2,367 | $-1,130 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -194 | -35 | N/A | N/A | N/A |
| Investing Cash Flow | $-194 | $-35 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -67 | N/A | N/A | N/A |
| Common Stock Issued | 8,618 | 110 | 110 | 93 | 57 |
| Other Financing Activity | -18 | 0 | -50 | -33 | -16 |
| Financing Cash Flow | $8,601 | $42 | $60 | $60 | $41 |
| Beginning Cash Position | 3,813 | 8,182 | 8,182 | 8,182 | 8,182 |
| End Cash Position | 11,428 | 3,813 | 4,733 | 5,875 | 7,092 |
| Net Cash Flow | $7,616 | $-4,369 | $-3,448 | $-2,307 | $-1,090 |
| Free Cash Flow | |||||
| Operating Cash Flow | -791 | -4,376 | -3,508 | -2,367 | -1,130 |
| Capital Expenditure | -194 | -35 | N/A | N/A | N/A |
| Free Cash Flow | -985 | -4,411 | -3,508 | -2,367 | -1,130 |